Kyverna Therapeutics, Inc. (KYTX)

Kyverna Therapeutics Analyst Ratings

KYTX's stock price has decreased by -54.88% in the past year and price targets may not have had time to catch up.

• Total Analysts: 5
• Consensus Rating: Strong Buy
• Price Target: $19.00
• Upside: +479.27%

Ratings History

Filter results

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Mitchell Kapoor HC Wainwright & Co.	HC Wainwright & Co.	Hold → Strong Buy Upgrades $4 → $5	Hold → Strong Buy	Upgrades	$4 → $5	+52.44%	May 27, 2025
Mitchell Kapoor HC Wainwright & Co.	HC Wainwright & Co.	Hold Maintains $6 → $4	Hold	Maintains	$6 → $4	+21.95%	Apr 3, 2025
Michael Ulz Morgan Stanley	Morgan Stanley	Buy Maintains $40 → $20	Buy	Maintains	$40 → $20	+509.76%	Apr 1, 2025
Mitchell Kapoor HC Wainwright & Co.	HC Wainwright & Co.	Hold Maintains $7 → $6	Hold	Maintains	$7 → $6	+82.93%	Nov 20, 2024
Derek Archila Wells Fargo	Wells Fargo	Buy Maintains $44 → $24	Buy	Maintains	$44 → $24	+631.71%	Nov 15, 2024
Trung Huynh UBS	UBS	Strong Buy Initiates $13	Strong Buy	Initiates	$13	+296.34%	Oct 10, 2024
Mitchell Kapoor HC Wainwright & Co.	HC Wainwright & Co.	Hold Reiterates $7	Hold	Reiterates	$7	+113.41%	Sep 19, 2024
Mitchell Kapoor HC Wainwright & Co.	HC Wainwright & Co.	Hold Maintains $8 → $7	Hold	Maintains	$8 → $7	+113.41%	Aug 15, 2024
Brian Cheng JP Morgan	JP Morgan	Buy Maintains $39 → $33	Buy	Maintains	$39 → $33	+906.10%	Jul 31, 2024
Mitchell Kapoor HC Wainwright & Co.	HC Wainwright & Co.	Hold Reiterates $8	Hold	Reiterates	$8	+143.90%	Jul 16, 2024
Mitchell Kapoor HC Wainwright & Co.	HC Wainwright & Co.	Hold Initiates $8	Hold	Initiates	$8	+143.90%	Jul 3, 2024
Brian Cheng JP Morgan	JP Morgan	Buy Initiates $39	Buy	Initiates	$39	+1,089.02%	Mar 4, 2024
Michael Ulz Morgan Stanley	Morgan Stanley	Buy Initiates $40	Buy	Initiates	$40	+1,119.51%	Mar 4, 2024